Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase

Keyphrases

• Phosphoinositide 3-kinase (PI3K) 100%
• Ultraviolet-B (UV-B) 100%
• Cyclooxygenase-2 Expression 100%
• Delphinidin 100%
• Cyclooxygenase-2 41%
• Prostaglandin E2 16%
• Skin Carcinogenesis 16%
• Transcription Factor 8%
• Oncogenesis 8%
• Molecular Mechanism 8%
• Overexpression 8%
• Phosphorylation 8%
• In Vivo Investigation 8%
• Protective Behavior 8%
• Pullout 8%
• Kinase Activity 8%
• Inflammatory Mediators 8%
• Mouse Skin 8%
• P38 MAP Kinase 8%
• Epidermal Cells 8%
• C-Jun N-terminal Kinase 8%
• Activator protein-1 (AP-1) 8%
• Adenosine Triphosphate 8%
• Promoter Activity 8%
• 1-factor 8%
• Nuclear factor-B 8%
• Non-cytotoxic 8%
• Sepharose 8%
• Mitogen-activated Protein Kinase Kinase 4 (MKK4) 8%
• Solar Irradiation 8%
• Monomeric Anthocyanins 8%
• Cytotoxic Concentration 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Cyclooxygenase 2 100%
• Phosphatidylinositol 3 Kinase 100%
• Delphinidin 100%
• Mouse 16%
• Phosphotransferase 16%
• Skin Carcinogenesis 16%
• Prostaglandin E2 16%
• Alternative Complement Pathway C3 C5 Convertase 8%
• Transcription Factor AP 1 8%
• Nuclear Factor 8%
• Sepharose 8%
• Mitogen Activated Protein Kinase Kinase 4 8%
• Inflammation 8%
• Transcription Factors 8%
• Adenosine Triphosphate 8%
• Carcinogenesis 8%